As presented in medical meetings, the new antioxidant drug succinobucol showed promising benefits in the prevention and treatment of diabetes.


© Buck McDaniel



Though side effects (aside from already known: diarrhea) and potential cardiovascular risks, still needs investigation, preliminary results on the drug and the full study is published in the May 24 issue of The Lancet.

According to study author Dr. Jean-Claude Tardif, director of the research center at the Montreal Heart Institute in Canada:

"There is more data in the article than in the previous presentation, with greater detail on the prevention of diabetes and glycemic [sugar] control.

There are several interesting findings that include a large reduction of new cases of diabetes and also glycemic control in patients who already have diabetes. But there needs to be confirmation before it is used widely, because there was no effect on clinical endpoints such as heart attack and stroke.

Some confirmation of the drug's effectiveness is expected from a major trial that is nearing completion. Results of that trial should be published "within the next few months"".

With the array of antioxidant products in the market these days, it is good to know that there is something for those with diabetes.

Read the full report from Forbes.